Allergies Clinical Trial
Official title:
Strengthening the Case for Ongoing Reduction of Exposure to Traffic-Related Air Pollution
The study probes the effects of combined exposures to diesel exhaust and allergens on lung function and on the immune system, specifically focusing on the ability of a particle depletion technique to attenuate effects we and others have seen previously. Individuals are exposed to either filtered air (FA), carefully controlled levels of diesel exhaust (DE) or particle-depleted diesel exhaust (PDDE) in our exposure chamber, after which the investigators will administer an inhaled allergen challenge. 48h later, a procedure called bronchoscopy is used to collect samples from the lungs. After 1 month, the entire procedure is to be repeated with one of the alternate exposures. This will be repeated 4 times (4 exposures; 2 filtered air, 1 diesel exhaust, 1 particle-depleted diesel exhaust)
1. Purpose/Objective:
The aim of this study is to investigate the ability of depletion of diesel exhaust
particles to attenuate adverse effects of diesel exhaust on lung function and on
allergic responses.
2. Hypotheses:
Hypothesis 1: Allergen-specific immune response (specific IgG4, etc; relevant responses
in DNA methylation and proteomics) in allergen-challenged airways in sensitized
individuals is increased by diesel exhaust "synergy".
Hypothesis 2: Synergistic responses will be greater in asthmatics than in
non-asthmatics.
Hypotheses 3: Synergy is attributable to the particulate fraction of DE (i.e. is
normalized by particle depletion).
3. Justification:
Diesel exhaust consists of both gaseous and particulate air pollutants. In recent
studies, cardiovascular effects seem attenuated when the particulate portion is removed.
We would like to know if that is true for respiratory and immunological endpoints.
Understanding these changes may help us prevent health problems associated with air
pollution in the future.
4. Research Method:
Blinded crossover experiment between four conditions (DE and allergen, PDDE and allergen, FA
and allergen, FA and saline), randomized and counter-balanced to order. Each condition will
be separated by a 4-week washout period.
An inhaled allergen or saline challenge is delivered after each exposure (DE, PDDE, or FA).
24 h post challenge, airway reactivity will be assessed with a methacholine challenge. 48 h
post challenge, bronchoalveolar lavage (BAL), airway brushes and tissue biopsies will be
obtained for analysis of immune activation. Nasal lavage samples will also be collected to
examine responses in the upper airways and blood and urine will be studied to examine
systemic responses. Spirometry and methacholine challenge will be used to assess effects on
airway function.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01612936 -
T Cell Effector and Regulatory Mechanisms in Asthma
|
Phase 1 | |
Completed |
NCT00779116 -
Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
|
Phase 4 | |
Recruiting |
NCT06002685 -
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
|
N/A | |
Completed |
NCT04644783 -
Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES)
|
N/A | |
Recruiting |
NCT05635266 -
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
Completed |
NCT01792232 -
Effects of Co-Exposure to Air Pollution and Allergen
|
N/A | |
Completed |
NCT01454505 -
Safety and Efficacy of AL-53817 Nasal Spray Solution
|
Phase 1 | |
Completed |
NCT00800332 -
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
|
Phase 2 | |
Terminated |
NCT04641000 -
The Alberta BLOOM Long Term Follow Up Study
|
||
Recruiting |
NCT05119868 -
Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring
|
N/A | |
Completed |
NCT00801502 -
Salmon in Pregnancy Study
|
N/A | |
Completed |
NCT00453583 -
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
|
N/A | |
Unknown status |
NCT00892684 -
Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease?
|
N/A | |
Completed |
NCT00700726 -
Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma
|
N/A | |
Recruiting |
NCT00350376 -
Impact of Asthma Treatments on Daily Activities
|
N/A | |
Completed |
NCT00881634 -
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
|
Phase 1 | |
Completed |
NCT00881127 -
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT03106493 -
Upstate New York Infant Development Screening Program
|
||
Completed |
NCT01711593 -
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
|
Phase 1 | |
Completed |
NCT01529437 -
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
|
Phase 1 |